The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s noninvasive prenatal testing market report forecasts the noninvasive prenatal testing market size to grow to $3.59 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The Noninvasive Prenatal Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/non-invasive-ventilators-global-market-report

Noninvasive Prenatal Testing Market Size Forecast
The global noninvasive prenatal testing market is expected to grow from $2.67 billion in 2022 to $2.82 billion in 2023 at a compound annual growth rate (CAGR) of 5.82%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global noninvasive prenatal testing market size is expected to reach $3.59 billion in 2027 at a CAGR of 6.19%.

North America held the largest noninvasive prenatal testing market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Noninvasive Prenatal Testing Market Driver ­– Rise In The Prevalence Of Respiratory Diseases
According to the World Health Organisation (WHO), a United Nations specialised agency based in Switzerland that is responsible for international public health, chronic noncommunicable diseases (NCDs) will kill approximately 41 million people annually in September 2022, accounting for 74% of all deaths worldwide. Chronic respiratory disorders alone account for 4.1 million fatalities. As a result, the rising prevalence of respiratory illnesses drives the market for non-invasive ventilators.

Request for A Sample Of The Global Noninvasive Prenatal Testing Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10321&type=smp

Key Noninvasive Prenatal Testing Market Trend – Technological Advancement
Companies in the non-invasive ventilator industry are embracing new technology in order to maintain their market position. For example, Philips Healthcare, a Dutch global conglomerate firm, will introduce its BiPAP A40 EFL ventilator system on the market in November 2020. This BiPAP A40 EFL ventilator is the first to assist healthcare providers in screening, detecting, and eliminating expiratory flow limitation in COPD patients with excessively increased blood carbon dioxide levels. The Philips Respironics E30 ventilator includes ExpiraFlow technology, which is designed to identify expiratory flow limitation (EFL) in COPD patients.

Noninvasive Prenatal Testing Market Segment
1) By Type: Continuous Positive Airway Pressure (CPAP), Autotitrating (Adjustable) Positive Airway Pressure (APAP), Bilevel Positive Pressure (BiPAP)
2) By Power Source: Electric, Pneumatic, Electro-Pneumatic
3) By Application: Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Pneumonia, Other Applications
4) By End-User: Hospitals, Specialty Clinics, Home Care Settings, Ambulatory Surgical Centers

Noninvasive Prenatal Testing Market Major Players and Strategies
Major players in the noninvasive prenatal testing market are ResMed Inc., Teleflex Incorporated, Hamilton Bonaduz AG, HEYER Medical AG, Airon Corporation, Fisher & Paykel Healthcare, Smiths Medical, O-Two Medical Technologies Inc., Phoenix Medical Systems Pvt. Ltd., Phillips Healthcare, Dragerwerk AG & Co. KGaA, General Electric Healthcare, Magnamed, WILAmed GmbH, Mindray Medical International Limited, Vyaire Medical, GETINGE AB and Medtronic PLC.

Medline International B.V., a Netherlands-based manufacturer of medical products and solutions, paid $286 million for Teleflex’s selected respiratory assets in May 2021. Medline hopes to enhance its position in the worldwide NIV market and grow its footprint in Europe and other international markets with this acquisition. Teleflex Incorporated is a speciality medical device manufacturing firm based in the United States that produces non-invasive ventilators for vascular and interventional access, surgical anaesthesia, cardiac care, urology, emergency medicine, and respiratory care.

The Noninvasive Prenatal Testing Global Market Report 2023 covers regional data on noninvasive prenatal testing market size, noninvasive prenatal testing market trends and drivers, opportunities, strategies, and noninvasive prenatal testing market competitor analysis. The countries covered in the noninvasive prenatal testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Non-invasive prenatal testing involves drawing blood from the mother and evaluating it for probable abnormalities in the patient. Non-invasive prenatal testing kits and equipment are used to detect genetic abnormalities, most notably chromosome problems, in foetuses during the first trimester of pregnancy.

View More Reports Related To The Noninvasive Prenatal Testing Market –
Noninvasive Prenatal Testing Global Market Report 2023
Ventilators Global Market Report 2023
Non-Animal Alternatives Testing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: